(Q33629375)

28 July 2017

title

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective (English)

1 reference

generalized anxiety disorder

28 July 2017

main subject

1 reference

inferred from title

author name string

Montserrat Vera-Llonch

1

1 reference

28 July 2017

Ellen Dukes

2

1 reference

28 July 2017

Javier Rejas

3

1 reference

28 July 2017

Oleg Sofrygin

4

1 reference

28 July 2017

Marko Mychaskiw

5

1 reference

28 July 2017

Gerry Oster

6

1 reference

28 July 2017

publication date

9 June 2009

1 reference

The European Journal of Health Economics

28 July 2017

published in

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

35-44

1 reference

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

The descriptive epidemiology of commonly occurring mental disorders in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Human and economic burden of generalized anxiety disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

The epidemiology of generalized anxiety disorder in Europe

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

The assessment of anxiety states by rating

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Modeling valuations for EuroQol health states

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Paroxetine efficacy in the treatment of generalized anxiety disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Utilization of medical specialists by anxiety disorder patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Quality-of-life-adjusted survival for comparing cancer treatments. A commentary on TWiST and Q-TWiST.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Treatment of peripheral neuropathic pain: a simulation model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Clinical practice. Generalized anxiety disorder.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Generalized anxiety and depression in primary care: prevalence, recognition, and management.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Cost-Effectiveness Analysis of Escitalopram Compared with Paroxetine in Treatment of Generalized Anxiety Disorder in the United Kingdom

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816249

Uncertainty in decision models analyzing cost-effectiveness

10 December 2018

1 reference

12 December 2020

[What is an efficient health technology in Spain?]

1 reference

12 December 2020

Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs

1 reference

12 December 2020

Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy

1 reference

12 December 2020

Estimation of symptom-free days in generalized anxiety disorder

1 reference

12 December 2020

Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy

1 reference

12 December 2020

Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients

1 reference

12 December 2020

10.1007/S10198-009-0160-7

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference